Bohnacker Sabine, Seitz Uwe, Nguyen Dzung, Thonke Frank, Seewald Stefan, deWeerth Andreas, Ponnudurai Ryan, Omar Salem, Soehendra Nib
Department for Interdisciplinary Endoscopy, Center of Internal Medicine, University Hospital Eppendorf, Hamburg, Germany.
Gastrointest Endosc. 2005 Oct;62(4):551-60. doi: 10.1016/j.gie.2005.04.053.
Endoscopic papillectomy of benign papillary tumor is still not widely practiced. Intraductal growth has been considered a contraindication for endoscopic therapy. This prospective study evaluates endoscopic papillectomy for treatment of benign papillary tumors without and with intraductal growth.
Monofilament snare and monopolar electrocoagulation were used for papillectomy. A 7F stent was placed in the pancreatic duct. Patients with distal intraductal growth underwent sphincterotomy and endoscopic resection after exclusion of more proximal growth.
Between February 1985 and April 2004, 106 patients (109 lesions), 68 women, 38 men, median age 68 years (range 29-88 years) were included. Median tumor size was 2 cm (range 0.5-6 cm) with one session (range 1-8) required for removal. Nine patients had invasive carcinoma (8%). Surgery for incomplete removal or recurrence was performed in 12% of 75 patients without and 37% of 31 patients with intraductal growth (p < 0.01), respectively. Fifteen patients had recurrence (15%); but, only 4 required surgery. Endoscopic resection was curative (median follow-up, 43 months) in 83% without and 46% with intraductal growth (p < 0.001).
Endoscopic papillectomy is safe and effective, and may be feasible in cases of intraductal growth. Surveillance and, if required, re-treatment are mandatory because of the risk of recurrence.
良性乳头瘤的内镜下乳头切除术仍未广泛应用。导管内生长一直被视为内镜治疗的禁忌证。本前瞻性研究评估内镜下乳头切除术治疗有无导管内生长的良性乳头瘤。
采用单丝圈套器和单极电凝进行乳头切除术。在胰管内放置一个7F支架。对于导管远端生长的患者,在排除更近端生长后进行括约肌切开术和内镜切除术。
1985年2月至2004年4月,纳入106例患者(109个病变),其中女性68例,男性38例,中位年龄68岁(范围29 - 88岁)。肿瘤中位大小为2 cm(范围0.5 - 6 cm),切除需要1次手术(范围1 - 8次)。9例患者有浸润性癌(8%)。75例无导管内生长患者和31例有导管内生长患者中,分别有12%和37%因切除不完全或复发而接受手术(p < 0.01)。15例患者复发(15%);但只有4例需要手术。无导管内生长患者中83%、有导管内生长患者中46%的内镜切除是治愈性的(中位随访43个月)(p < 0.001)。
内镜下乳头切除术安全有效,对于导管内生长的病例可能也是可行的。由于存在复发风险,监测以及必要时的再次治疗是必需的。